Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J R Foster

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Journal of Pharmaceutical Sciences|May 27, 2006
Cerebral kinetics of oxycodone in conscious sheepHanne H Villesen, David J R Foster, Richard N Upton, et al.
Basic & Clinical Pharmacology & Toxicology|December 9, 2010
Pharmacokinetic/pharmacodynamic relationships of transdermal buprenorphine and fentanyl in experimental human pain modelsTrine Andresen, Richard N Upton, David J R Foster, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 16, 2016
Intracellular CD3+ T Lymphocyte Teriflunomide Concentration Is Poorly Correlated with and Has Greater Variability Than Unbound Plasma Teriflunomide ConcentrationAshley M Hopkins, Mahin Moghaddami, David J R Foster, et al.
British Journal of Clinical Pharmacology|July 5, 2024
Pharmacokinetic-pharmacodynamic modelling and simulation of methotrexate dosing in patients with rheumatoid arthritisJiun Ming Tan, Richard N Upton, David J R Foster, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 1, 2011
Simple HPLC method for determination of rosiglitazone in sheep plasma and amniotic fluid and its application in a pregnant sheep modelMaryam Bazargan, Andrew K Davey, Beverly S Muhlhausler, et al.
Clinical Pharmacology and Therapeutics|May 13, 2022
Population Pharmacokinetics and Pharmacodynamics of the Therapeutic and Adverse Effects of Ketamine in Patients With Treatment-Refractory DepressionAhmad Y Abuhelwa, Andrew A Somogyi, Colleen K Loo, et al.
Scientific Reports|October 30, 2020
Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugsAhmad Y Abuhelwa, Ashley M Hopkins, Michael J Sorich, et al.
Cancer Chemotherapy and Pharmacology|September 8, 2019
Development of a physiologically based pharmacokinetic model for intravenous lenalidomide in miceJim H Hughes, Richard N Upton, Stephanie E Reuter, et al.
British Journal of Clinical Pharmacology|September 3, 2015
Genetic polymorphism of CYP1A2 but not total or free teriflunomide concentrations is associated with leflunomide cessation in rheumatoid arthritisAshley M Hopkins, Michael D Wiese, Susanna M Proudman, et al.
Clinical Pharmacokinetics|September 30, 2010
A pharmacokinetic and pharmacodynamic study of oral oxycodone in a human experimental pain model of hyperalgesiaAnne E Olesen, Richard Upton, David J R Foster, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Journal of Pharmaceutical Sciences|May 27, 2006
Cerebral kinetics of oxycodone in conscious sheepHanne H Villesen, David J R Foster, Richard N Upton, et al.
Basic & Clinical Pharmacology & Toxicology|December 9, 2010
Pharmacokinetic/pharmacodynamic relationships of transdermal buprenorphine and fentanyl in experimental human pain modelsTrine Andresen, Richard N Upton, David J R Foster, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 16, 2016
Intracellular CD3+ T Lymphocyte Teriflunomide Concentration Is Poorly Correlated with and Has Greater Variability Than Unbound Plasma Teriflunomide ConcentrationAshley M Hopkins, Mahin Moghaddami, David J R Foster, et al.
British Journal of Clinical Pharmacology|July 5, 2024
Pharmacokinetic-pharmacodynamic modelling and simulation of methotrexate dosing in patients with rheumatoid arthritisJiun Ming Tan, Richard N Upton, David J R Foster, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 1, 2011
Simple HPLC method for determination of rosiglitazone in sheep plasma and amniotic fluid and its application in a pregnant sheep modelMaryam Bazargan, Andrew K Davey, Beverly S Muhlhausler, et al.
Clinical Pharmacology and Therapeutics|May 13, 2022
Population Pharmacokinetics and Pharmacodynamics of the Therapeutic and Adverse Effects of Ketamine in Patients With Treatment-Refractory DepressionAhmad Y Abuhelwa, Andrew A Somogyi, Colleen K Loo, et al.
Scientific Reports|October 30, 2020
Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugsAhmad Y Abuhelwa, Ashley M Hopkins, Michael J Sorich, et al.
Cancer Chemotherapy and Pharmacology|September 8, 2019
Development of a physiologically based pharmacokinetic model for intravenous lenalidomide in miceJim H Hughes, Richard N Upton, Stephanie E Reuter, et al.
British Journal of Clinical Pharmacology|September 3, 2015
Genetic polymorphism of CYP1A2 but not total or free teriflunomide concentrations is associated with leflunomide cessation in rheumatoid arthritisAshley M Hopkins, Michael D Wiese, Susanna M Proudman, et al.
Clinical Pharmacokinetics|September 30, 2010
A pharmacokinetic and pharmacodynamic study of oral oxycodone in a human experimental pain model of hyperalgesiaAnne E Olesen, Richard Upton, David J R Foster, et al.
Pageof 6